De Witte Jan 4
4 · RESMED INC · Filed Nov 14, 2024
Insider Transaction Report
Form 4
RESMED INCRMD
De Witte Jan
Director
Transactions
- Sale
ReMed Common Stock
2024-11-12$248.81/sh−796$198,053→ 6,723 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.